About: Response of metastatic breast cancer to trastuzumab?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Response of metastatic breast cancer to trastuzumab? Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) wüsseschaftlicher Artikel, wo im Johr 2000 veröffentlicht worden isch (gsw) наукова стаття, опублікована в січні 2000 (uk) im Januar 2000 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 2000 (ast) artikull shkencor i botuar më 01 janar 2000 (sq) scientific article published on 01 January 2000 (en)
publication date	wds:Q73449530-BC47DBF3-4FC7-4FB7-8728-CD9D402BED15
publication date	2000-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73449530-D754021F-23E0-40B1-93D6-3334FBBF2B23
language of work or name	English
cites work	wds:Q73449530-02ED489A-FC5D-4A1B-9B11-3A0AD94D2D14 wds:Q73449530-0C790C23-CDD9-403E-B3B6-85B8D704B154 wds:Q73449530-0FC549BF-5375-4A5D-908C-7BFB02580728 wds:Q73449530-1BD8FE10-536A-4E1A-8C6C-332FBEEF337C wds:Q73449530-46028F70-903E-409B-8C28-0CFE4272CEEC wds:Q73449530-5245406F-8BF8-4135-9EBE-F6AA480DC202 wds:Q73449530-5DECFC81-8B4C-491A-84E8-7961FB4337A2 wds:Q73449530-5FD8BD7A-D41A-4B00-A97A-0407D064BD0A wds:Q73449530-68DA90EE-C453-4FF2-A7C1-D35736058AD8 wds:Q73449530-D753EBE7-75EC-40CB-B63A-0CF9B4396D5E wds:Q73449530-EB1E5E84-E979-4336-87F5-6FC93178AB8A
cites work	First MAb approved for treatment of metastatic breast cancer. Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system Monoclonal antibodies directed to the erbB-2 receptor inhibit in vivo tumour cell growth Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer HER-2/neu testing comes of age Using HER2 to choose chemotherapy in breast cancer: is it ready for the clinic?
author name string	wds:Q73449530-E93DB455-AE96-4243-ACC7-15DB3FA6CF1D wds:Q73449530-F0FA2C5B-7DC0-4F3E-AF82-8E0EC6E23ADE
author name string	D W Miles D M Barnes
rdfs:label	Response of metastatic breast cancer to trastuzumab? (en) Response of metastatic breast cancer to trastuzumab? (nl) Response of metastatic breast cancer to trastuzumab? (sq)
skos:prefLabel	Response of metastatic breast cancer to trastuzumab? (en) Response of metastatic breast cancer to trastuzumab? (nl) Response of metastatic breast cancer to trastuzumab? (sq)
name	Response of metastatic breast cancer to trastuzumab? (en) Response of metastatic breast cancer to trastuzumab? (nl) Response of metastatic breast cancer to trastuzumab? (sq)
title	wds:Q73449530-67B8A759-88E3-4004-95D8-F52C2A654606
title	Response of metastatic breast cancer to trastuzumab? (en)
page(s)	wds:Q73449530-D0359453-0225-429C-BDC7-F5F3870EE058
page(s)	160-161
instance of	wds:Q73449530-58545716-A588-453F-B9C9-9FF19864EE07
instance of	scholarly article
main subject	wds:Q73449530-861AF944-3CBE-43AB-BE9F-372D0CCD5BA5
main subject	metastatic breast cancer
PubMed ID	wds:Q73449530-61636942-3192-4FF9-95FA-E0F000C84B62
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10675110
PubMed ID	10675110
published in	wds:Q73449530-0AE14B82-D5AE-425D-A43B-AF00760042BF
published in	The Lancet
issue	wds:Q73449530-6C2F8D5C-66B4-40F4-A946-DFCA21D97C74
volume	wds:Q73449530-865EB143-8B9C-4C6B-833F-152007C9842C
issue	9199
volume	355
DOI	wds:Q73449530-83F58A5B-6ECC-41E3-983F-CEAD28774B08
DOI	http://dx.doi.org/10.1016/S0140-6736(99)00430-4
DOI	10.1016/S0140-6736(99)00430-4
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73449530
is cites work of	EGFR and HER2 expression in primary cervical cancers and corresponding lymph node metastases: implications for targeted radiotherapy Recent advances in anti-angiogenic therapy of cancer Therapeutic applications of monoclonal antibodies Whither high-dose chemotherapy in breast cancer?
is cites work of	wds:Q33359764-835DB251-0FB0-4434-BFE9-7458D19D7531 wds:Q37852512-A080F6F0-97AB-477E-A120-9A18C6B8809F wds:Q24801121-7391BCA5-5ED5-45C4-AB9B-6B8365FC6277 wds:Q34743728-21A7E50C-F20D-455E-87A9-7A12816CA3C0

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software